145 related articles for article (PubMed ID: 34084740)
1. Diagnostic Performance of Vascular Permeability and Texture Parameters for Evaluating the Response to Neoadjuvant Chemoradiotherapy in Patients With Esophageal Squamous Cell Carcinoma.
Ji W; Wang J; Zhou R; Wang M; Wang W; Pang P; Kong M; Zhou C
Front Oncol; 2021; 11():604480. PubMed ID: 34084740
[TBL] [Abstract][Full Text] [Related]
2. Does the computed tomography perfusion imaging improve the diagnostic accuracy in the response evaluation of esophageal carcinoma to the neoadjuvant chemoradiotherapy? Preliminary study.
Djuric-Stefanovic A; Saranovic D; Micev M; Stankovic V; Plesinac-Karapandzic V; Pesko P; Stojakov D; Sabljak P; Bjelovic M
J BUON; 2014; 19(1):237-44. PubMed ID: 24659670
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy.
Sun NN; Liu C; Ge XL; Wang J
Diagn Interv Radiol; 2018 Jul; 24(4):195-202. PubMed ID: 30091709
[TBL] [Abstract][Full Text] [Related]
4. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic performance of dynamic contrast-enhanced magnetic resonance imaging parameters and serum tumor markers in rectal carcinoma prognosis.
Mu RQ; Lv JW; Ma CY; Ma XH; Xing D; Ma HS
World J Gastrointest Oncol; 2024 May; 16(5):1796-1807. PubMed ID: 38764818
[TBL] [Abstract][Full Text] [Related]
6. Assessment of esophageal carcinoma undergoing concurrent chemoradiotherapy with quantitative dynamic contrast-enhanced magnetic resonance imaging.
Lei J; Han Q; Zhu S; Shi D; Dou S; Su Z; Xu X
Oncol Lett; 2015 Dec; 10(6):3607-3612. PubMed ID: 26788177
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide Study.
Okamura A; Watanabe M; Okui J; Matsuda S; Takemura R; Kawakubo H; Takeuchi H; Muto M; Kakeji Y; Kitagawa Y; Doki Y
Ann Surg Oncol; 2023 Sep; 30(9):5885-5894. PubMed ID: 37264286
[TBL] [Abstract][Full Text] [Related]
8. SUV
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
[TBL] [Abstract][Full Text] [Related]
9. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
[TBL] [Abstract][Full Text] [Related]
10. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Sun NN; Ge XL; Liu XS; Xu LL
Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
[TBL] [Abstract][Full Text] [Related]
11. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
Zou HH; Yu J; Wei Y; Wu JF; Xu Q
J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
[TBL] [Abstract][Full Text] [Related]
12. PET-Uptake Reduction into Lymph Nodes After Neoadjuvant Therapy is Highly Predictive of Prognosis for Patients Who have Thoracic Esophageal Squamous Cell Carcinoma Treated with Chemoradiotherapy Plus Esophagectomy.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Kemuriyama K; Sasaki Y; Imai K; Maeda E; Minamiya Y
Ann Surg Oncol; 2022 Feb; 29(2):1336-1346. PubMed ID: 34355333
[TBL] [Abstract][Full Text] [Related]
13. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemoradiotherapy Upregulates the Immunogenicity of Cold to Hot Tumors in Esophageal Cancer Patients.
Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Kemuriyama K; Sasamori R; Nozaki S; Nomura K; Minamiya Y
Ann Surg Open; 2024 Mar; 5(1):e385. PubMed ID: 38883957
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MRI and
Xu X; Sun ZY; Wu HW; Zhang CP; Hu B; Rong L; Chen HY; Xie HY; Wang YM; Lin HP; Bai YR; Ye Q; Ma XM
Radiat Oncol; 2021 Jul; 16(1):132. PubMed ID: 34281566
[TBL] [Abstract][Full Text] [Related]
16. Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience.
De Cecco CN; Ciolina M; Caruso D; Rengo M; Ganeshan B; Meinel FG; Musio D; De Felice F; Tombolini V; Laghi A
Abdom Radiol (NY); 2016 Sep; 41(9):1728-35. PubMed ID: 27056748
[TBL] [Abstract][Full Text] [Related]
17. Rad51 expression is a useful predictive factor for the efficacy of neoadjuvant chemoradiotherapy in squamous cell carcinoma of the esophagus.
Nakanoko T; Saeki H; Morita M; Nakashima Y; Ando K; Oki E; Ohga T; Kakeji Y; Toh Y; Maehara Y
Ann Surg Oncol; 2014 Feb; 21(2):597-604. PubMed ID: 24065387
[TBL] [Abstract][Full Text] [Related]
18. Role of intravoxel incoherent motion MRI in early assessment of the response of esophageal squamous cell carcinoma to chemoradiotherapy: A pilot study.
Zheng H; Ren W; Pan X; Zhang Q; Liu B; Liu S; He J; Zhou Z
J Magn Reson Imaging; 2018 Aug; 48(2):349-358. PubMed ID: 29297204
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.
Saeki H; Morita M; Nakashima Y; Sonoda H; Hashimoto K; Egashira A; Oki E; Ohga T; Kakeji Y; Maehara Y
Anticancer Res; 2011 Sep; 31(9):3073-7. PubMed ID: 21868562
[TBL] [Abstract][Full Text] [Related]
20. Decreases in the Psoas Muscle Index Correlate More Strongly with Survival than Other Prognostic Markers in Esophageal Cancer After Neoadjuvant Chemoradiotherapy Plus Esophagectomy.
Kawakita Y; Motoyama S; Sato Y; Wakita A; Nagaki Y; Imai K; Minamiya Y
World J Surg; 2020 May; 44(5):1559-1568. PubMed ID: 31907570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
